SIRION Biotech
AcquiredMunich, Germany · Founded 2003
- Headquarters
- Munich
- Founded
- 2003
- Business Model
- B2B
- Website
- sirion-biotech.com
- Rounds
- 2
- Acquired by
- PerkinElmerJun 2021
About
SIRION Biotech GmbH was a Munich, Germany-based biotech company, founded in 2003, that developed vector-based technologies -- including AAV, lentivirus, and adenovirus platforms -- for cell and gene therapy research, drug discovery, and preclinical development. In 2021 it was acquired by PerkinElmer (now Revvity); its viral vector expertise and 20+ years of gene delivery experience now live on within Revvity's Gene Delivery business unit.
Summary
SIRION Biotech is a Biotech company based in Munich, Germany, founded in 2003. Investors include High-Tech Grunderfonds, Creathor Ventures and Bayern Kapital.
Funding & Exit History
Jun 2021
Sign up to see all 3 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sirion-biotech"><img src="https://indexed.vc/api/badge/company/sirion-biotech" alt="SIRION Biotech on Indexed.vc" width="260" height="76" /></a>